Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Biocon

Sector: Healthcare | Industry: Drugs & Pharma
R 258.05 -1.90  | -0.73% -18.92% 31.23 30,978.00
NSE Price: Oct 17, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 15:59 258.05 -1.90 -0.73% 257.60 259.95 2,271,152 255.00 - 258.85
BSE Oct 17, 2019 258.15 -1.75 -0.67% 257.50 259.90 109,619 255.00 - 258.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue5,856.505,514.404,123.403,891.103,347.40 3,089.802,877.30
Other Income132.30144.40206.20157.1079.20 53.1055.90
Total Income5,988.805,658.804,329.604,048.203,426.60 3,142.902,933.20
Total Expenditure4,295.704,120.703,294.302,911.602,579.60 2,394.002,190.20
Operating Profit1,693.101,538.101,035.301,136.60847.00 748.90743.00
Interest69.9070.9061.5026.0029.30 8.901.70
PBDT1,623.201,467.20973.801,110.60817.70 740.00741.30
Depreciation472.90447.80385.10277.20248.70 221.00203.60
PBT & Exceptional Items1,150.301,019.40588.70833.40569.00 519.00537.70
Exceptional Items194.60194.60--160.60 105.10-
Profit before Tax1,344.901,214.00588.70833.40729.60 624.10537.70
Provision for Tax245.40212.30156.90161.60142.20 95.70106.90
Profit after Tax1,099.501,001.70431.80671.80587.40 528.40430.80
Minority Interest-100.10-97.30-80.70-76.00-58.70 -31.00-17.00
Share of Associate-7.500.9021.3016.3021.70 --
Consolidated Profit991.90905.30372.40612.10550.40 497.40413.80
 
LiabilitiesR Cr
Share Capital300.00300.00300.00100.00100.00 100.00100.00
Total Reserves5,798.005,720.804,812.304,670.203,933.80 3,132.702,806.20
Shareholder's Funds6,098.006,098.005,180.804,837.704,033.80 3,270.603,026.70
Minority Interest608.90608.90467.70376.10265.80 172.2082.30
Long Term Borrowings1,541.601,541.601,789.802,108.202,072.40 769.60606.20
Other Non Current Liabilities906.30906.30410.10393.90420.40 608.30655.80
Current Liabilities3,037.603,037.602,141.301,678.301,665.70 1,554.701,379.60
Total Debt*-2,423.002,264.002,302.502,477.70 1,117.20863.70
Total Liabilities12,192.4012,192.409,989.709,394.208,458.10 6,375.405,750.60
 
AssetsR Cr
Net Block5,056.604,471.003,699.503,625.101,748.30 1,629.901,525.20
Non Current Investments182.50182.5063.80188.8026.80 -64.50
Other Non-Current Assets2,130.502,716.102,077.801,532.602,712.10 2,182.901,522.10
Current Investments829.30829.30611.401,065.00874.70 230.30700.40
Cash and Bank1,057.201,057.201,322.801,044.301,538.60 937.50804.40
Other Current Assets2,936.302,936.302,214.401,938.401,557.60 1,394.801,134.00
Net Current Assets1,785.201,785.202,007.302,369.402,305.20 1,007.901,259.20
Miscellaneous Exp. Not Written Off----- --
Total Assets12,192.4012,192.409,989.709,394.208,458.10 6,375.405,750.60
 
Cash FlowR Cr
From Operations-1,154.60662.10640.00370.60 210.70560.70
From Investing Activities--713.80-684.00-498.50-1,141.70 -508.70-938.10
From Finance Activities--241.70-239.70-177.501,067.60 186.20426.00
Net Inflow/Outflow-199.10-261.60-36.00296.50 -111.8048.60
 
Key Ratios
Adjusted EPS (Rs)8.277.543.105.104.59 4.153.45
Adjusted Book Value (Rs)54.6350.1742.6039.7433.61 26.9324.21
Dividend per Share (Rs)-1.001.003.005.00 5.005.00
Cash Flow per Share (Rs)-19.2411.0432.0018.53 10.5428.04
Debt to Equity0.250.400.440.480.61 0.350.30
Current Ratio1.591.591.942.412.38 1.651.91
ROCE (%)-16.108.9212.5913.93 15.3015.75
RONW (%)19.5018.008.7415.2616.17 17.2215.68
Operating Margin (%)28.9127.8925.1129.2125.30 24.2425.82
Net Margin (%)18.3617.709.9716.6017.14 16.8114.69
Revenue Growth (%)35.5733.735.9716.248.34 7.3915.77
Net Profit Growth (%)130.99131.98-35.7214.3711.17 22.66-15.97
EPS Growth (%)141.46143.10-39.1611.2110.66 20.20-18.69
Book Value Growth (%)-17.777.1718.2624.79 11.2412.13
 
Market Cues
Close Price (Rs)258.05305.28296.95188.7280.56 78.2270.73
High Price (Rs)341.85359.00328.75193.8290.76 92.2782.90
Low Price (Rs)211.05271.65147.5280.3665.88 67.0544.12
Market Cap (Rs Cr)30,978.0036,660.0035,652.0022,670.009,642.00 9,390.008,481.00
Price / Earnings31.2340.4995.7437.0417.52 18.8820.50
Price / Book Value4.736.096.974.752.39 2.912.92
Dividend Yield (%)0.190.160.170.261.04 1.061.18
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
5.08
Piotroski F-Score
8
Modified C-Score
0
5-Years Price to Earnings
31.23
5-Years Price to Book
4.73
Earnings Yield
EBIT / Enterprise value
4.49%
PEG
Price / Earnings to growth ratio
1.56
Related Stocks
  Current Price   Chng %
Abbott India R10,984.05 +0.32%
Alkem Laboratories R1,918.85 +0.23%
Cadila Healthcare R237.80 +1.32%
Cipla R446.30 -0.11%
Glaxosmithkline Pharma R1,440.10 +0.76%
Lupin R726.50 -0.87%
Pfizer R3,195.65 +0.15%
Piramal Enterprises R1,468.85 +6.77%
Sanofi India R6,052.80 +1.21%
Torrent Pharmaceuticals R1,694.50 +3.19%
As on Oct 17, 15:59